1. Altered intracellular region of MUC1 and disrupted correlation of polarity‐related molecules in breast cancer subtypes. Issue 3 (12th February 2015) Authors: Iizuka, Misato; Nakanishi, Yoko; Fuchinoue, Fumi; Maeda, Tetsuyo; Murakami, Eriko; Obana, Yukari; Enomoto, Katsuhisa; Tani, Mayumi; Sakurai, Kenichi; Amano, Sadao; Masuda, Shinobu Journal: Cancer science Issue: Volume 106:Issue 3(2015:Mar.) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50. Issue 1 (27th November 2020) Authors: Ozawa, Yuichi; Harutani, Yuhei; Oyanagi, Jun; Akamatsu, Hiroaki; Murakami, Eriko; Shibaki, Ryota; Hayata, Atsushi; Sugimoto, Takeya; Tanaka, Masanori; Takakura, Toshiaki; Furuta, Katsuyuki; Okuda, Yuka; Sato, Kouichi; Teraoka, Shunsuke; Ueda, Hiroki; Tokudome, Nahomi; Kitamura, Yuka; Fukuoka, Jun... Journal: Cancer science Issue: Volume 112:Issue 1(2021) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab. (January 2018) Authors: Sato, Koichi; Akamatsu, Hiroaki; Murakami, Eriko; Sasaki, Seigo; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Koh, Yasuhiro; Ueda, Hiroki; Nakanishi, Masanori; Yamamoto, Nobuyuki Journal: Lung cancer Issue: Volume 115(2018) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71–74]. (December 2018) Authors: Sato, Koichi; Akamatsu, Hiroaki; Murakami, Eriko; Sasaki, Seigo; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Koh, Yasuhiro; Ueda, Hiroki; Nakanishi, Masanori; Yamamoto, Nobuyuki Journal: Lung cancer Issue: Volume 126(2018) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial. Issue 12 (11th December 2019) Authors: Murakami, Eriko; Akamatsu, Hiroaki; Shimokawa, Toshio; Wada, Kiyoko; Yamamoto, Nobuyuki Journal: BMJ open Issue: Volume 9:Issue 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer. (19th November 2019) Authors: Akamatsu, Hiroaki; Murakami, Eriko; Oyanagi, Jun; Shibaki, Ryota; Kaki, Takahiro; Takase, Eri; Tanaka, Masanori; Harutani, Yuhei; Yamagata, Nao; Okuda, Yuka; Furuta, Katsuyuki; Sugimoto, Takeya; Teraoka, Shunsuke; Hayata, Atsushi; Tokudome, Nahomi; Ozawa, Yuichi; Mori, Keita; Koh, Yasuhiro; Yamam... Journal: Oncologist Issue: Volume 25:Number 4(2020) Page Start: e679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗